Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin vs Cefazolin for SSI Prevention in Craniotomy
NCT03466645Phase 2Unknown
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vancomycin in surgical site infection (SSI). Status: unknown.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03466645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03466645.